Skip to main content
. 2017 Apr 4;164(1):221–229. doi: 10.1007/s10549-017-4225-5

Fig. 1.

Fig. 1

Kaplan–Meier curves of individual HER2 receptor-positive breast cancer subtypes. a, b Luminal B HER2 DFS and OS (respectively). c, d HER2+(ER−) DFS and OS (respectively). DFS Disease-Free Survival, OS Overall survival, Trast +ve: Patients treated with Trastuzumab, Trats −ve +: Patients who did not receive Trastuzumab